AAPL   268.52 (-1.83%)
FB   188.30 (-0.76%)
MSFT   159.60 (+0.90%)
AMZN   1,855.65 (-1.52%)
BABA   201.16 (-1.89%)
MU   51.96 (+2.73%)
AMD   44.41 (+0.91%)
ACB   1.36 (-6.21%)
NFLX   367.00 (-1.27%)
AAPL   268.52 (-1.83%)
FB   188.30 (-0.76%)
MSFT   159.60 (+0.90%)
AMZN   1,855.65 (-1.52%)
BABA   201.16 (-1.89%)
MU   51.96 (+2.73%)
AMD   44.41 (+0.91%)
ACB   1.36 (-6.21%)
NFLX   367.00 (-1.27%)
AAPL   268.52 (-1.83%)
FB   188.30 (-0.76%)
MSFT   159.60 (+0.90%)
AMZN   1,855.65 (-1.52%)
BABA   201.16 (-1.89%)
MU   51.96 (+2.73%)
AMD   44.41 (+0.91%)
ACB   1.36 (-6.21%)
NFLX   367.00 (-1.27%)
AAPL   268.52 (-1.83%)
FB   188.30 (-0.76%)
MSFT   159.60 (+0.90%)
AMZN   1,855.65 (-1.52%)
BABA   201.16 (-1.89%)
MU   51.96 (+2.73%)
AMD   44.41 (+0.91%)
ACB   1.36 (-6.21%)
NFLX   367.00 (-1.27%)
Log in

Anika Therapeutics SEC Filings & 10K Form (NASDAQ:ANIK)

$41.24
+0.12 (+0.29 %)
(As of 02/28/2020 11:31 AM ET)
Today's Range
$40.46
Now: $41.24
$41.50
50-Day Range
$40.34
MA: $43.85
$50.13
52-Week Range
$29.01
Now: $41.24
$75.71
Volume3,523 shs
Average Volume182,142 shs
Market Capitalization$588.49 million
P/E Ratio21.71
Dividend YieldN/A
Beta0.97

SEC Filings

Anika Therapeutics (NASDAQ:ANIK) SEC Filings

DateFilerForm TypeView
02/27/2020
5:54 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:53 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:53 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:52 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:51 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:50 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:49 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:48 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:47 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
11:56 AM
Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/06/2020
4:12 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2019
3:06 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:40 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:20 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/30/2019
3:05 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:05 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:06 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:06 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:05 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:00 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2019
3:06 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
3:10 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
3:05 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
3:10 PM
Anika Therapeutics (Filer)
Form DEFA14A
04/25/2019
3:05 PM
Anika Therapeutics (Filer)
Form DEF 14A
04/12/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
7:30 AM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:36 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:36 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:34 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:33 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:32 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:32 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:31 PM
Anika Therapeutics (Issuer)
BOWER JOSEPH I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:31 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:30 PM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
7:38 AM
Anika Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
7:52 AM
Anika Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
02/06/2019
8:15 AM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
8:15 AM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
7:38 AM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
3:30 PM
Anika Therapeutics (Subject)
Form SC 13G/A
10/30/2018
3:05 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2018
3:21 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2018
3:10 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
3:05 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2018
3:06 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
7:30 AM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
3:15 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
3:10 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2018
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
4:28 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2018
3:06 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2018
4:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2018
3:17 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
1:00 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2018
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2018
3:06 PM
Anika Therapeutics (Filer)
Form DEFA14A
04/17/2018
3:05 PM
Anika Therapeutics (Filer)
Form DEF 14A
04/06/2018
3:06 PM
Anika Therapeutics (Filer)
Form PRE 14A
03/22/2018
3:30 PM
Anika Therapeutics (Subject)
SHERWOOD CHARLES H (Filed by)
Form SC 13G/A
03/13/2018
3:05 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2018
4:17 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2018
3:07 PM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
3:06 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
3:06 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
3:06 PM
Anika Therapeutics (Issuer)
SHERWOOD CHARLES H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2018
8:13 PM
Anika Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2018
4:30 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
10:35 AM
Anika Therapeutics (Subject)
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/12/2018
8:37 AM
Anika Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2018
8:12 AM
Anika Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
01/26/2018
3:12 PM
Anika Therapeutics (Issuer)
WHEELER STEVE E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
3:06 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
3:06 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
3:06 PM
Anika Therapeutics (Issuer)
BOWER JOSEPH I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
3:05 PM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2018
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2017
3:05 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Google Finance Portfolio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel